Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Talon Therapeutics Looks Undervalued Following FDA Approval
Talon Therapeutics Looks Undervalued Following FDA Approval
Talon Therapeutics Looks Undervalued Following FDA Approval
Submitted by
admin
on August 12, 2012 - 11:05am
Source:
Seeking Alpha
News Tags:
Talon Therapeutics
Marqibo
acute lymphoblastic leukemia
Headline:
Talon Therapeutics Looks Undervalued Following FDA Approval
Do Not Allow Advertisers to Use My Personal information
